Investment Analysts’ updated eps estimates for Monday, December 11th:

Barrick Gold (TSE:ABX) (NYSE:ABX) had its hold rating reaffirmed by analysts at Desjardins.

Agnico Eagle Mines (TSE:AEM) (NYSE:AEM) had its buy rating reaffirmed by analysts at Desjardins. Desjardins currently has a C$60.00 price target on the stock.

Alamos Gold (TSE:AGI) (NYSE:AGI) had its hold rating reissued by analysts at Desjardins.

Aviva (OTCMKTS:AVVIY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $16.00 target price on the stock. According to Zacks, “Aviva has established a competitive position in North America. In the US, the world’s largest savings market, Aviva is the leading provider of indexed annuity and indexed life insurance products. Its principal activity is the provision of financial products and services, focused on the following lines of business: long-term insurance and savings business, fund management and general insurance and health. The company’s business is managed on a geographic basis through a regional management structure based on four regions, U.K., Europe, North America and Asia Pacific. The four regions function as five operating segments as, due to the size of the U.K. region, it is split into two operating segments, U.K. Life and U.K. General Insurance, which undertake long term insurance and savings business and general insurance respectively. “

Axalta Coating Systems (NYSE:AXTA) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “Axalta Coating Systems Ltd. is a global coatings company engaged in the manufacturing, marketing and distribution of coatings systems. The company offers waterborne and solvent borne coatings; liquid and powder coatings; and liquid coatings. It provides a range of performance and transportation coatings for manufacturers of light and commercial vehicles, the refinish aftermarket and for many industrial applications. The Company’s products and services include paint, color matching tools, application technologies and customer training, support and business management systems. Axalta Coating Systems Ltd. is headquartered in Philadelphia, Pennsylvania. “

Peabody Energy (NYSE:BTU) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. Zacks Investment Research currently has $39.00 price target on the stock. According to Zacks, “Peabody Energy Corporation is a coal company. It provides voice in advocating for sustainable mining, energy access and clean coal technologies. The company serves metallurgical and thermal coal customers primarily in Arizona, Colorado, New Mexico and Wyoming, Illinois, Indiana and Australia. Peabody Energy Corporation is based in St Louis, United States. “

Detour Gold (TSE:DGC) had its buy rating reissued by analysts at Desjardins.

Eldorado Gold (TSE:ELD) (NYSE:EGO) had its hold rating reissued by analysts at Desjardins.

First Quantum Minerals (TSE:FM) was upgraded by analysts at Goldman Sachs Group Inc from a neutral rating to a buy rating.

Franco-Nevada (TSE:FNV) (NYSE:FNV) had its sell rating reiterated by analysts at Desjardins.

Liberty Media (NASDAQ:FWONA) was upgraded by analysts at FBN Securities from a sector perform rating to an outperform rating.

Goldcorp (TSE:G) (NYSE:GG) had its hold rating reiterated by analysts at Desjardins.

IAMGOLD (TSE:IMG) (NYSE:IAG) had its buy rating reissued by analysts at Desjardins.

Kinross Gold (TSE:K) (NYSE:KGC) had its sell rating reaffirmed by analysts at Desjardins.

Keyera (TSE:KEY) had its outperform rating reissued by analysts at BMO Capital Markets. BMO Capital Markets currently has a C$43.00 target price on the stock.

Kura Oncology (NASDAQ:KURA) had its buy rating reissued by analysts at Cann. The firm currently has a $17.50 price target on the stock. The analysts wrote, “Kura Oncology had three positive presentations for its lead compound, Tipifarnib, at the 2017 American Society of Hematology meeting, from December 9-11. These included preliminary phase II analysis in CMML and PTCL, and a biomarker study. We found these studies very encouraging for Tipifarnib’s use in hematologic cancers. Our outlook for 2020-22 remains basically unchanged, and we estimate that Tipifarnib could result in sales as early as 2019. We currently estimate Tipifarnib could result in 2022 product sales of $1.1 billion. The data presented at 2017 ASH are very supportive of our outlook.””

Mullen Group (TSE:MTL) was downgraded by analysts at National Bank Financial from an outperform rating to a sector perform rating. They currently have C$16.50 price target on the stock, down from their previous price target of C$18.25.

New Gold (TSE:NGD) (ARCA:NGD) had its sell rating reissued by analysts at Desjardins.

Osisko Gold Royalties (TSE:OR) had its buy rating reissued by analysts at Desjardins.

PACCAR (NASDAQ:PCAR) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “PACCAR is well-positioned in its key markets on the back of its strategic investments and a strong balance sheet, enabling it to undertake capital investments and research and development expenses. It also has an expanded network presence, enabling it to provide high-quality aftermarket products and services to its customers. Development and production of new products and services plus an active capital deployment policy are a few of the other benefits that PACCAR has. However, tough competition in the commercial truck market and declining prices of used trucks are its few concerns. Also, year to date, its shares have underperformed in the industry it belongs to.”

Philip Morris International (NYSE:PM) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Shares of Philip Morris have declined in the past three months, underperforming the industry. Though the company has been benefiting from enhanced volumes and revenues in the reduced risk products category, it has been suffering majorly due to consistent declines in cigarette volumes stemming from the shift of customer preference away from tobacco products. Owing to such headwinds, Phillip Morris continued with its drab performance in third-quarter 2017, wherein both earnings and revenues lagged the Zacks Consensus Estimate. These factors also compelled management to lower its 2017 view. Nevertheless, Philip Morris’ consistent efforts to improve the performance of its low risk products remain encouraging. In this category, the company’s IQOS smokeless cigarette have been steadily expanding owing to consumer demand.  Higher cigarette pricing has also been favoring the company.”

Polar Capital (LON:POLR) had its hold rating reissued by analysts at Investec. They currently have a GBX 510 ($6.86) price target on the stock.

Royal Bank of Canada (TSE:RY) (NYSE:RY) was upgraded by analysts at Eight Capital from a neutral rating to a buy rating. They currently have C$113.00 price target on the stock, up from their previous price target of C$107.00.

Sage Therapeutics (NASDAQ:SAGE) had its buy rating reaffirmed by analysts at Cowen Inc.

U.S. Silica (NYSE:SLCA) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “U.S. Silica is well placed to gain from its expansion initiatives in the fast-growing Permian Basin. It also remains focused on pursuing earnings-accretive acquisitions. The Sandbox acquisition is driving sales and margins in the company’s oil and gas business and is expected to make a meaningful contribution in 2017. U.S. Silica is also focusing on preserving capital, reducing costs, improving customer satisfaction and boosting its market position. However, U.S. Silica faces headwinds from an uncertain demand environment for frac sand. The company is also seeing significant cash outflows. Its stretched valuation is another concern.”

Needham & Company LLC started coverage on shares of Semtech (NASDAQ:SMTC). They issued a buy rating on the stock.

Constellation Brands (NYSE:STZ) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Constellation Brands has surpassed the broader industry year to date, backed by superb surprise history and constant brand-building efforts. The company has been gaining from its efforts to drive consumer demand for its robust brand portfolio. Also, focus on buyouts and continued strength in the beer business has been fuelling its results. Thanks to these endeavours, the company marked its 17th straight quarter of year-over-year earnings growth and 12th straight positive surprise in second-quarter fiscal 2018. The splendid results marked by significant market share gains, solid execution and strong free cash flow keeps management encouraged. Driven by these factors and confidence in its beer segment, management raised its earnings view for fiscal 2018 and operating income target for the beer segment. However, stiff competition and higher taxes remain concerns. Also, the company remains exposed to macroeconomic headwinds.”

Suncor Energy (TSE:SU) (NYSE:SU) had its outperform rating reaffirmed by analysts at BMO Capital Markets. BMO Capital Markets currently has a C$52.00 target price on the stock.

Torex Gold Resources (TSE:TXG) had its hold rating reissued by analysts at Desjardins.

Verastem (NASDAQ:VSTM) had its buy rating reiterated by analysts at Raymond James Financial, Inc..

Wheaton Precious Metals (TSE:WPM) had its buy rating reissued by analysts at Desjardins.

Acceleron Pharma (NASDAQ:XLRN) had its buy rating reissued by analysts at HC Wainwright. They currently have a $62.00 target price on the stock.

Yamana Gold (TSE:YRI) (NYSE:AUY) had its hold rating reissued by analysts at Desjardins.

Receive News & Ratings for Barrick Gold Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Barrick Gold Co and related companies with MarketBeat.com's FREE daily email newsletter.